Avion
Integrated CRO offering end‑to‑end trial management and AI‑enhanced imaging solutions for pharma, biotech and medical‑device clients.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Integrated CRO offering end‑to‑end trial management and AI‑enhanced imaging solutions for pharma, biotech and medical‑device clients.
OncologyDermatologyRadiopharmaceuticals
Technology Platform
Proprietary AI-driven imaging segmentation (MOOSE) and integrated cloud data management (Avi.Data) combined with the Avi.Suite workflow platform for end‑to‑end clinical trial execution.
Opportunities
Expanding demand for AI‑enhanced imaging and centralized data platforms in oncology and radiopharmaceutical trials, plus leveraging Australia's R&D tax incentives to attract international sponsors.
Risk Factors
Reliance on external pharma/biotech sponsors for revenue and competition from larger global CROs with broader service portfolios.
Competitive Landscape
Competes with global CROs such as IQVIA, ICON and Charles River, differentiating through specialized imaging expertise and AI‑driven analytics.